Usmarapride

目录号: PL02307 纯度: ≥98%
Usmarapride (SUVN-D4010) 是一种有效的、具有选择性、口服活性和可透过血脑屏障的 5-HT4 受体部分激动剂 (EC50=nM)。Usmarapride (SUVN-D4010) 可用于阿尔茨海默病相关认知缺陷的研究。
CAS No. :1428862-33-2
商品编号 规格 价格 会员价 是否有货 数量
PL02307-5mg 5mg ¥5464.00 请登录
PL02307-10mg 10mg ¥8679.00 请登录
PL02307-50mg 50mg 询价 询价
PL02307-100mg 100mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Usmarapride
英文名称
Usmarapride
英文别名
Usmarapride;1JPX7J35CG;2-[1-(3-methoxypropyl)piperidin-4-yl]-5-(1-propan-2-ylindazol-3-yl)-1,3,4-oxadiazole;oxalic acid;SUVN-D4010 oxalate
Cas No.
1428862-33-2
分子式
C23H31N5O6
分子量
473.52
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
详情描述
Usmarapride (SUVN-D4010) 是一种有效的、具有选择性、口服活性和可透过血脑屏障的 5-HT4 受体部分激动剂 (EC50=nM)。Usmarapride (SUVN-D4010) 可用于阿尔茨海默病相关认知缺陷的研究。
产品详情
Usmarapride (SUVN-D4010) 是一种有效的、具有选择性、口服活性和可透过血脑屏障的 5-HT4 受体部分激动剂 (EC50=nM)。Usmarapride (SUVN-D4010) 可用于阿尔茨海默病相关认知缺陷的研究。
生物活性
Usmarapride (SUVN-D4010) is a potent, selective, orally active and brain penetrant 5-HT 4 receptor partial agonist (EC 50 =44 nM). Usmarapride (SUVN-D4010) can be used for the research of cognitive deficits associated with Alzheimers disease.
性状
Solid
IC50 & Target[1][2]
5-HT4 Receptor 44 nM (EC50)
体内研究(In Vivo)
Usmarapride (SUVN-D4010) (1-3 mg/kg; p.o.; Male Wistar rats 10-12 weeks old) attenuates the long-term memory deficits in object recognition test (ORT).
Usmarapride (1, 3, and 10 mg/kg; p.o.) significantly reverses the scopolamine-induced amnesia.
Usmarapride shows a statistically significant effect at 3.0 mg/kg on both exploration time and recognition index.
Usmarapride (SUVN-D4010) shows good oral exposures, good bioavailability, and good brain exposures in rats.
Pharmacokinetic of Usmarapride in Rats
(3.0 mg/kg for p.o. dosing; 1.0 mg/kg for i.v.)
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Nirogi, Ramakrishna; Mohammed, Abdul Rasheed; Yarlgadda, Suresh; Ravella, Srinivasa Rao; Shinde, Anil Karbhari; Kambhampati, Ramasastri; Roayalley, Praveen Kumar; Jayarajan, Pradeep; Bhyrapuneni, Gopinadh; Patnala, Sriramachandra Murthy; et al. Preparatio
溶解度数据
In Vitro: DMSO : 33.33 mg/mL (70.39 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. Nirogi, Ramakrishna; Mohammed, Abdul Rasheed; Yarlgadda, Suresh; Ravella, Srinivasa Rao; Shinde, Anil Karbhari; Kambhampati, Ramasastri; Roayalley, Praveen Kumar; Jayarajan, Pradeep; Bhyrapuneni, Gopinadh; Patnala, Sriramachandra Murthy; et al. Preparatio

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2